Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 16551-16600 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03620942
Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System
NA
Active, not recruiting
173 participants
Started: Nov 7, 2018 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03672539
Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome
PHASE2
Active, not recruiting
50 participants
Started: Nov 7, 2018 · Completed: Nov 30, 2025
6 conditions
2 sponsors
1 location
NCT03667404
Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study
PHASE2
Active, not recruiting
30 participants
Started: Nov 6, 2018 · Completed: Mar 31, 2026
3 conditions
2 sponsors
1 location
NCT03712566
Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy
N/A
Active, not recruiting
39 participants
Started: Nov 6, 2018 · Completed: Jul 31, 2026
5 conditions
1 sponsor
1 location
NCT03703375
Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma
PHASE3
Active, not recruiting
93 participants
Started: Nov 6, 2018 · Completed: Mar 31, 2026
1 condition
1 sponsor
12 locations
NCT03734107
Improving Health Communication During the Transition From Pediatric to Adult Diabetes Care
NA
Active, not recruiting
52 participants
Started: Nov 6, 2018 · Completed: Dec 15, 2024
1 condition
2 sponsors
1 location
NCT03581292
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations
PHASE2
Active, not recruiting
38 participants
Started: Nov 6, 2018 · Completed: Oct 16, 2025
3 conditions
1 sponsor
163 locations
NCT03740282
Early Weight-Bearing After the Lapiplasty Procedure
NA
Active, not recruiting
183 participants
Started: Nov 6, 2018 · Completed: May 31, 2026
2 conditions
1 sponsor
7 locations
NCT03661320
A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer
PHASE3
Active, not recruiting
855 participants
Started: Nov 6, 2018 · Completed: Dec 30, 2027
2 conditions
2 sponsors
172 locations
NCT03729739
Functional Assessment by Virtual Online Reconstruction. The FAVOR III Europe Trial
NA
Active, not recruiting
2,001 participants
Started: Nov 6, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
35 locations
NCT03686007
Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients
NA
Active, not recruiting
380 participants
Started: Nov 6, 2018 · Completed: Jan 13, 2026
10 conditions
2 sponsors
1 location
NCT03652064
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
PHASE3
Active, not recruiting
395 participants
Started: Nov 6, 2018 · Completed: Jan 9, 2026
1 condition
1 sponsor
114 locations
NCT03734237
A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD
PHASE4
Active, not recruiting
15,449 participants
Started: Nov 6, 2018 · Completed: May 31, 2024
3 conditions
8 sponsors
9 locations
NCT03716180
DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC
PHASE1
Active, not recruiting
100 participants
Started: Nov 5, 2018 · Completed: Sep 1, 2030
1 condition
4 sponsors
5 locations
NCT03570931
A Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal Dystrophy
PHASE2/PHASE3
Active, not recruiting
19 participants
Started: Nov 5, 2018 · Completed: Jun 30, 2022
1 condition
1 sponsor
2 locations
NCT03608579
Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA
PHASE1
Active, not recruiting
24 participants
Started: Nov 5, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03206086
Eltrombopag for People With Fanconi Anemia
PHASE2
Active, not recruiting
25 participants
Started: Nov 2, 2018 · Completed: Aug 1, 2028
1 condition
1 sponsor
1 location
NCT03742661
Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis
NA
Active, not recruiting
5 participants
Started: Nov 2, 2018 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT03337087
Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer
PHASE1/PHASE2
Active, not recruiting
18 participants
Started: Nov 2, 2018 · Completed: Aug 9, 2025
9 conditions
2 sponsors
3 locations
NCT04458207
Cognitive Changes and Neural Correlates After Rehabilitation of Masticatory Function in Elderly -an Intervention Study
NA
Active, not recruiting
80 participants
Started: Nov 2, 2018 · Completed: Dec 30, 2027
6 conditions
3 sponsors
2 locations
NCT04991519
Brain-based Understanding of Individual Language Differences After Stroke
N/A
Active, not recruiting
400 participants
Started: Nov 1, 2018 · Completed: Aug 30, 2028
3 conditions
4 sponsors
1 location
NCT03885960
Perthes Disease in Norway
N/A
Active, not recruiting
216 participants
Started: Nov 1, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04150822
CHORUS - Comprehensive HHT Outcomes Registry of the United States (Formerly OUR HHT Registry)
N/A
Active, not recruiting
296 participants
Started: Nov 1, 2018 · Completed: Jun 30, 2028
3 conditions
3 sponsors
1 location
NCT03703830
tDCS Associated With Locomotor Training on Functional Mobility of Cerebellar Ataxia
NA
Active, not recruiting
20 participants
Started: Nov 1, 2018 · Completed: Jul 31, 2024
1 condition
1 sponsor
1 location
NCT03921671
Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT)
PHASE2
Active, not recruiting
60 participants
Started: Nov 1, 2018 · Completed: Jul 16, 2024
2 conditions
1 sponsor
1 location
NCT03407547
A Study Exploring Brain Activity in Relation to Sensory Arm Impairments in the Early Stages of Stroke
NA
Active, not recruiting
20 participants
Started: Nov 1, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03741790
Airway Management of Pediatric Patients With Klippel-Feil Syndrome
N/A
Active, not recruiting
300 participants
Started: Nov 1, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03672201
Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia
NA
Active, not recruiting
187 participants
Started: Nov 1, 2018 · Completed: Dec 31, 2025
3 conditions
4 sponsors
6 locations
NCT03785093
Intestinal Microbiota on Allergy, Growth and Development
N/A
Active, not recruiting
120 participants
Started: Nov 1, 2018 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT03329365
Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS
N/A
Active, not recruiting
200 participants
Started: Nov 1, 2018 · Completed: Mar 29, 2025
4 conditions
2 sponsors
1 location
NCT03695315
Tissue-specific Insulin Resistance in Obstructive Sleep Apnea: Role of Hypoxia
N/A
Active, not recruiting
60 participants
Started: Oct 31, 2018 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT05203770
Adaptations of the Brain in Chronic Pain With Opioid Exposure I
N/A
Active, not recruiting
250 participants
Started: Oct 31, 2018 · Completed: Jun 30, 2024
2 conditions
3 sponsors
2 locations
NCT04294199
Effect of Early Range of Motion Following First Time Patellar Dislocation
NA
Active, not recruiting
60 participants
Started: Oct 31, 2018 · Completed: Aug 11, 2026
1 condition
1 sponsor
1 location
NCT03732820
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
PHASE3
Active, not recruiting
895 participants
Started: Oct 31, 2018 · Completed: Apr 27, 2026
1 condition
2 sponsors
132 locations
NCT03317405
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
PHASE1
Active, not recruiting
32 participants
Started: Oct 31, 2018 · Completed: Aug 12, 2026
13 conditions
1 sponsor
3 locations
NCT03681210
Destination Therapy Post Approval Study
N/A
Active, not recruiting
300 participants
Started: Oct 31, 2018 · Completed: Apr 30, 2026
1 condition
1 sponsor
47 locations
NCT03672773
Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
PHASE2
Active, not recruiting
35 participants
Started: Oct 31, 2018 · Completed: Oct 1, 2026
2 conditions
3 sponsors
6 locations
NCT03705234
A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease
PHASE3
Active, not recruiting
16,124 participants
Started: Oct 30, 2018 · Completed: Dec 31, 2049
1 condition
3 sponsors
2 locations
NCT03814252
Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer
NA
Active, not recruiting
62 participants
Started: Oct 30, 2018 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT03635424
Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
NA
Active, not recruiting
150 participants
Started: Oct 30, 2018 · Completed: Dec 31, 2030
1 condition
1 sponsor
25 locations
NCT03707743
Registry of Patients With Acute/Subacute Type B Aortic Dissection Treated by Means of the STABILISE Technique (STABILISE)
N/A
Active, not recruiting
200 participants
Started: Oct 30, 2018 · Completed: Dec 30, 2025
1 condition
1 sponsor
34 locations
NCT03235245
Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib
PHASE2
Active, not recruiting
271 participants
Started: Oct 30, 2018 · Completed: Jan 31, 2027
2 conditions
1 sponsor
38 locations
NCT07136324
Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry
N/A
Active, not recruiting
100 participants
Started: Oct 30, 2018 · Completed: Jul 1, 2028
1 condition
1 sponsor
1 location
NCT03203330
A Study to Determine the Safety and Efficacy of TG-C in Subjects with Kellgren and Lawrence Grade 2 or 3 OA of the Knee
PHASE3
Active, not recruiting
535 participants
Started: Oct 30, 2018 · Completed: Jul 10, 2026
1 condition
1 sponsor
46 locations
NCT03653052
Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab
PHASE2
Active, not recruiting
18 participants
Started: Oct 30, 2018 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT03904173
Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer
N/A
Active, not recruiting
2,300 participants
Started: Oct 29, 2018 · Completed: Dec 31, 2043
3 conditions
3 sponsors
5 locations
NCT03741127
Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
PHASE1
Active, not recruiting
100 participants
Started: Oct 29, 2018 · Completed: Nov 30, 2032
1 condition
2 sponsors
13 locations
NCT03596645
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
PHASE3
Active, not recruiting
84 participants
Started: Oct 29, 2018 · Completed: Feb 20, 2027
1 condition
1 sponsor
58 locations
NCT03569956
Shaving Satisfaction in Males With Skin Irritation From Shaving
NA
Active, not recruiting
40 participants
Started: Oct 29, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03575013
A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer
PHASE1
Active, not recruiting
21 participants
Started: Oct 29, 2018 · Completed: Feb 23, 2026
1 condition
3 sponsors
1 location
Previous
1
More pages
329
330
331
332
333
334
335
More pages
431
Next